The expression of gangliosides GD2 is associated with worse prognosis in melanoma patients

被引：1
|
作者：
Kong, Yan
Yu, Jiayi
Si, Lu
Chi, Zhihong
Cui, Chuanliang
Sheng, Xinan
Guo, Jun
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2303
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2303
引用
收藏
页数：4
相关论文
共 50 条
  • [21] GANGLIOSIDE GD2 EXPRESSION IS MAINTAINED UPON RECURRENCE IN PATIENTS WITH OSTEOSARCOMA
    Poon, V., I
    Roth, M.
    Piperdi, S.
    Geller, D.
    Gill, J.
    Ridzinski, E. R.
    Hawkins, D. S.
    Gorlick, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (01) : 201 - 201
  • [22] Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3
    Shibuya, Hidenobu
    Hamamura, Kazunori
    Hotta, Hiroshi
    Matsumoto, Yasuyuki
    Nishida, Yoshihiro
    Hattori, Hisashi
    Furukawa, Keiko
    Ueda, Minoru
    Furukawa, Koichi
    CANCER SCIENCE, 2012, 103 (09) : 1656 - 1664
  • [23] GD2 expression in Merkel cell carcinoma
    Orouji, A.
    Orouji, E.
    Ludwig-Peitsch, W.
    Goerdt, S.
    Utikal, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 55 - 56
  • [24] Frequency of ALK and GD2 Expression in Neuroblastoma
    Aygun, Zeynep
    Batur, Sebnem
    Emre, Senol
    Celkan, Tiraje
    Ozman, Oktay
    Comunoglu, Nil
    FETAL AND PEDIATRIC PATHOLOGY, 2019, 38 (04) : 326 - 334
  • [25] EXPRESSION CLONING OF BETA-1,4 N-ACETYLGALACTOSAMINYLTRANSFERASE CDNAS THAT DETERMINE THE EXPRESSION OF GM2 AND GD2 GANGLIOSIDES
    NAGATA, Y
    YAMASHIRO, S
    YODOI, J
    LLOYD, KO
    SHIKU, H
    FURUKAWA, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (17) : 12082 - 12089
  • [26] Disialoganglioside GD2 in Breast Cancer and its Influence on Prognosis
    Erber, R.
    Kailayangiri, S.
    Huebner, H.
    Ruebner, M.
    Hartmann, A.
    Haeberle, L.
    Meyer, J.
    Mackensen, A.
    Landgraf, L.
    Schulz-Wendtland, R.
    Beckmann, M. W.
    Fasching, P. A.
    Farwick, N.
    Roessig, C.
    Gass, P.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (07) : 742 - 742
  • [27] Neuroblastic Tumors with Expression of Disialoglycosphingolipids GD2 and/or GD3
    Nishimaki, Haruna
    Nakanishi, Yoko
    Masuda, Shinobu
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1741 - 1742
  • [28] GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer
    Galan, Alba
    Papaluca, Arturo
    Nejatie, Ali
    Matanes, Emad
    Brahimi, Fouad
    Tong, Wenyong
    Hachim, Ibrahim Yaseen
    Yasmeen, Amber
    Carmona, Euridice
    Klein, Kathleen Oros
    Billes, Sonja
    Dawod, Ahmed E.
    Gawande, Prasad
    Jeter, Anna Milik
    Mes-Masson, Anne-Marie
    Greenwood, Celia M. T.
    Gotlieb, Walter H.
    Saragovi, H. Uri
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [29] Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2
    Mizutani, K
    Oka, N
    Kusunoki, S
    Kaji, R
    Kanda, M
    Akiguchi, I
    Shibasaki, H
    INTERNAL MEDICINE, 2003, 42 (03) : 277 - 280
  • [30] Neuroblastic Tumors with Expression of Disialoglycosphingolipids GD2 and/or GD3
    Nishimaki, Haruna
    Nakanishi, Yoko
    Masuda, Shinobu
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1741 - 1742
12345